Carlyle eyes $1 billion raise via auto, healthcare IPOs

Global private equity powerhouse Carlyle is making waves in India, gearing up for two significant Initial Public Offering (IPO) by mid-2027, aiming to collectively raise an estimated $1 billion. These highly anticipated listings involve its automotive platform, Highway Roop Precision Technologies, eyeing a $500 million raise at a $2 billion valuation, and a newly consolidated healthcare Revenue Cycle Management (RCM) platform projected to bring in $400-500 million. This bold double play underscores Carlyle deep commitment and strategic focus on the burgeoning Indian market, leveraging both traditional manufacturing strength and the rapidly growing healthcare tech sector for substantial exits. The strategic timing of these IPO taps into a robust, albeit discerning, Indian primary market that saw a measured pace in early 2026 but maintains a strong pipeline of domestic investor interest. Carlyle automotive venture, Highway Roop Precision Technologies, established through the merger of Highway Industries and Roop Automotives in early 2025, is a key player in critical auto components for both traditional and Electric Vehicle (EV) markets, positioning it against formidable listed competitors like Bharat Forge and Sona BLW Precision Forgings. Meanwhile, the healthcare RCM platform, forged by integrating Knack RCM and EqualizeRCM in May 2026, aims to capitalize on India's burgeoning healthcare IT outsourcing capabilities, offering services to US providers with a strong emphasis on AI-native solutions. With investment bankers already pitching for mandates, the market will closely watch how these offerings are structured, likely featuring a combination of primary and secondary share sales. Carlyle, a highly active investor in India with over $8 billion deployed and a track record of successful exits like SBI Cards, is further solidifying its 'India for the World' thesis with these moves. These IPO are poised not just to provide Carlyle with lucrative exits but also to inject significant capital into India's vibrant automotive and healthcare sectors, potentially catalyzing further private equity activity and M&A in the region. The successful navigation of these listings will serve as a bellwether for investor confidence in India's growth story heading into late 2020s.